Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.50 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14117921 | 1.00 | TSHR (1.00) | TSHRTP53CYP2D6RECQLLMNA | |
| SCHEMBL221678 | 1.00 | TSHR (1.00) | TSHRTP53CYP2D6RECQLLMNA | |
| SCHEMBL7685 | 1.00 | TSHR (1.00) | TSHRTP53CYP2D6RECQLLMNA | |
| SCHEMBL11886503 | 1.00 | TSHR (1.00) | TSHRTP53CYP2D6RECQLLMNA | |
| SCHEMBL670257 | 1.00 | TSHR (1.00) | TSHRTP53CYP2D6RECQLLMNA | |
| Ammonia Solution, Strong SCHEMBL11444695 | 0.98 | TSHR (0.96) | TSHRTP53CYP2D6RECQLLMNA | |
| SCHEMBL28150719 | 0.98 | TSHR (0.96) | TSHRTP53CYP2D6RECQLLMNA | |
| Water SCHEMBL312080 | 0.98 | TSHR (0.96) | TSHRTP53CYP2D6RECQLLMNA | |
| Water SCHEMBL365251 | 0.98 | TSHR (0.96) | TSHRTP53CYP2D6RECQLLMNA | |
| SCHEMBL28149702 | 0.98 | TSHR (0.96) | TSHRTP53CYP2D6RECQLLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2671 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132108-A1 | PREPARATION OF MESEMBRINE | KANNA HEALTH LTD (GB) | 2026-05-14 | — | — | US | claimed |
| CN-122010930-A | Method for preparing refined crystals of non-nefardone and intermediate by using non-nefardone racemate | 罗欣药业(上海)有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260125390-A1 | SOLID FORMS OF MACROCYCLIC COMPOUNDS, SALTS AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE SAME | KURA ONCOLOGY INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4234546-B1 | IMPROVED SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND | AMGEN INC (US) | 2026-04-15 | — | — | EP | claimed |
| EP-4720073-A1 | SOLID FORMS OF A MACROCYCLIC FARNESYLTRANSFERASE INHIBITOR AND FORMULATIONS THEREOF, AND METHODS OF PREPARING AND USING THE MACROCYCLIC COMPOUND AND ITS SOLID FORMS | Kura Oncology, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| US-12473281-B2 | Synthesis of KRAS G12C inhibitor compound | AMGEN INC. (US) | 2025-11-18 | — | — | US | claimed |
| EP-4598904-A1 | PREPARATION OF MESEMBRINE | Kanna Health Limited (GB) | 2025-08-13 | — | — | EP | claimed |
| US-20250215005-A1 | PROCESS FOR PREPARATION OF RUXOLITINIB | ALIVUS LIFE SCIENCES LIMITED (IN) | 2025-07-03 | — | — | US | claimed |
| US-20250206736-A1 | SYNTHESIS OF KRAS G12C INHIBITOR COMPOUND | AMGEN INC. (US) | 2025-06-26 | — | — | US | claimed |
| WO-2025133917-A1 | PROCESS FOR THE PREPARATION OF (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5- ETHOXY-1, 4-DIHYDRO-2,8-DIMETHYL-1,6-NAPTHYRIDINE-3-CARBOXAMIDE | INDUSTRIALE CHIMICA S.R.L. (IT) | 2025-06-26 | — | — | WO | claimed |
| EP-0141408-B1 | PROCESS FOR THE PREPARATION OF L(-)CARNITINE HYDROCHLORIDE AND OF L(-)CARNITINE INNER SALT | ISOM S.p.A. (IT) | 1989-08-23 | — | — | EP | claimed |
| EP-0107825-B1 | 1,3,4,6,7,11B-HEXAHYDRO-7-ARYL-2H-PYRAZINO (2,1-ALPHA) ISOQUINOLINES USEFUL AS INTERMEDIATES AND PHARMACEUTICAL COMPOUNDS AND METHODS OF PREPARATION | PENNWALT CORPORATION (US) | 1988-03-02 | — | — | EP | claimed |
| US-4658060-A | Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide | SCHERING CORPORATION (US) | 1987-04-14 | — | — | US | claimed |
| EP-0092787-B1 | PROCESS FOR THE PREPARATION OF A PHENYLALKYLAMINOETHYLSALICYLAMIDE | SCHERING CORPORATION (US) | 1986-08-27 | — | — | EP | claimed |
| EP-0141408-A2 | Process for the preparation of L(-)carnitine hydrochloride and of L(-)carnitine inner salt | ISOM S.p.A. (IT) | 1985-05-15 | — | — | EP | claimed |
| EP-0107825-A1 | 1,3,4,6,7,11b-Hexahydro-7-aryl-2H-pyrazino (2,1-alpha) isoquinolines useful as intermediates and pharmaceutical compounds and methods of preparation | PENNWALT CORPORATION (US) | 1984-05-09 | — | — | EP | claimed |
| EP-0092787-A1 | Process for the preparation of a phenylalkylaminoethylsalicylamide | SCHERING CORPORATION (US) | 1983-11-02 | — | — | EP | claimed |
| US-4370500-A | Compound: d-N-(2-amino-2-phenethyl)-2-methoxyethylamine and process for preparing the same by selective crystallization | AMERICAN CYANAMID COMPANY (US) | 1983-01-25 | — | — | US | claimed |
| EP-0029175-B1 | PROCESS FOR THE OBTENTION OF THE ENANTIOMERIC FORMS OF 4-CYANE-1-(N-METHYL-N-(2'-((3\",4\"-DIMETHOXYPHENYL))ETHYL-AMINO)-5-METHYL-4-(3',4',5'-TRIMETHOXYPHENYL) HEXANE AND ITS SALTS | BASF Aktiengesellschaft (DE) | 1982-12-15 | — | — | EP | claimed |
| EP-0010851-A2 | Process for the preparation of tetramisole | AMERICAN CYANAMID COMPANY (US) | 1980-05-14 | — | — | EP | claimed |